Vaccines News: FDA Approves First Self-Administered Flu Infection Vaccine
Friday, 20 September 2024, 10:19
FDA Approval of FluMist for Home Use
The recent approval of FluMist by the FDA marks a significant advancement in vaccines aimed at combating flu infections. Individuals can now self-administer this nasal spray vaccine at home, transforming how flu prevention is approached.
FluMist: Key Features
- First of its kind: The first self-administered influenza vaccine.
- Prescription required: Patients must still obtain a prescription to access FluMist.
- Age Limit: Self-administration is available for those 18 years and older.
Implications for Vaccine Access
This critical development in vaccines could lead to a higher vaccination rate, as barriers to access are significantly reduced.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.